Astera Labs (NASDAQ:ALAB – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07, FiscalAI reports. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.The firm had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. During the same period last year, the company earned $0.37 earnings per share. The company’s revenue for the quarter was up 91.8% on a year-over-year basis. Astera Labs updated its Q1 2026 guidance to 0.530-0.540 EPS.
Here are the key takeaways from Astera Labs’ conference call:
- Astera reported strong financials with $270.6M in Q4 revenue (+17% QoQ, +92% YoY), FY2025 revenue of $852.5M (+115% YoY), and Q1 guidance of $286M–$297M with ~74% non‑GAAP gross margin and EPS of $0.53–$0.54.
- Multiple product ramps and design wins are driving growth: Scorpio P is in volume at lead customers, Scorpio X shipped pre‑prod and targets H2 2026 ramps, Aries PCIe‑6 retimers and Taurus 400G modules saw large YoY growth, and Leo CXL has a Microsoft/Intel/SAP program targeting production H2 2026.
- Astera filed a warrant agreement with Amazon issuing 3.3M warrants that could convert into up to $6.5B of product purchases if milestones are met, a strong commercial endorsement (the company warns vesting warrants will create a non‑cash accounting charge estimated to lower gross margins by ~2 pts/quarter once recognized).
- Management is significantly increasing R&D and headcount (including the Xscale acquisition, an acqui‑hire, and a new Israel design center) with Q1 non‑GAAP OpEx guided to $112M–$118M, indicating near‑term margin pressure to fund long‑term growth.
- Management says the addressable opportunity expanded markedly — estimating a company SAM of $25B (merchant scale‑up switching ~$20B by 2030) with public endorsements for UALink from AWS and AMD for 2027 and optical scale‑up deployments targeted around 2028.
Astera Labs Trading Down 21.4%
Shares of ALAB stock opened at $143.71 on Thursday. The company has a market capitalization of $24.27 billion, a price-to-earnings ratio of 117.80, a PEG ratio of 2.49 and a beta of 1.50. The firm has a 50-day moving average price of $165.25 and a 200 day moving average price of $174.42. Astera Labs has a twelve month low of $47.13 and a twelve month high of $262.90.
Insider Buying and Selling at Astera Labs
Hedge Funds Weigh In On Astera Labs
Institutional investors have recently added to or reduced their stakes in the business. Amundi boosted its stake in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares during the last quarter. Voloridge Investment Management LLC purchased a new position in shares of Astera Labs during the 3rd quarter worth about $131,539,000. Holocene Advisors LP acquired a new stake in shares of Astera Labs in the second quarter worth approximately $55,827,000. State Street Corp grew its holdings in Astera Labs by 39.3% in the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after purchasing an additional 604,363 shares during the period. Finally, Deutsche Bank AG grew its holdings in Astera Labs by 157.9% in the fourth quarter. Deutsche Bank AG now owns 981,712 shares of the company’s stock valued at $163,318,000 after purchasing an additional 600,985 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on ALAB. Royal Bank Of Canada initiated coverage on shares of Astera Labs in a research note on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 target price for the company. Needham & Company LLC raised their price objective on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. BNP Paribas Exane assumed coverage on Astera Labs in a research note on Thursday, November 20th. They set an “outperform” rating for the company. Finally, Barclays set a $165.00 price target on Astera Labs in a report on Thursday, January 15th. Fourteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $192.89.
Read Our Latest Research Report on Astera Labs
Key Headlines Impacting Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Q4 beat and strong guidance: Astera reported record Q4 revenue of $270.6M (up 92% YoY), EPS $0.58 topping estimates, and issued Q1 EPS guidance of $0.53–$0.54 (well above consensus) plus revenue guidance above Street views — a clear fundamental beat and near-term upside to results. GlobeNewswire release
- Positive Sentiment: High margins and cash generation: Gross margins remained strong (~75.7%) with healthy net margin and cash flow metrics noted in commentary, supporting profitable scaling as AI infrastructure demand grows. Seeking Alpha analysis
- Neutral Sentiment: Longer-term ramp timing: Management signaled Scorpio X volumes are modest in early 2026 with meaningful ramps weighted to H2 and into 2027 — positive long-term but a timing mismatch versus some near-term expectations. Seeking Alpha analysis
- Neutral Sentiment: Analyst views mixed but constructive: JPMorgan highlighted Astera’s exposure to AI infrastructure (Nvidia/AMD/Amazon/Google) as upside for 2026, while Citi trimmed its price target (still a buy) — showing differing time-horizons among analysts. Benzinga/JPMorgan note
- Negative Sentiment: Market selling despite beats: Shares dropped sharply after the print — investors cited expectations/positioning and profit-taking from recent highs; several outlets called the move a “crash” despite the beat. Invezz coverage
- Negative Sentiment: Customer concentration / deal scrutiny: Coverage raised concerns about a large Amazon-related deal (reported as ~$6.5B) creating concentration risk or deal-structural questions — a major reason for investor caution. MarketWatch analysis
- Negative Sentiment: CFO transition adds near-term uncertainty: Management announced a CFO change (new CFO appointed, prior CFO to strategic advisor), which, combined with other items above, intensified selling pressure. Company press release
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- Is THIS the Next Big Money Rush?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- Washington knows what’s coming. Do you?
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
